Why is Boston Bio falling/rising?

As of 07-Jul, Boston Bio Systems Ltd is experiencing a decline in its stock price, currently at 7.17, which reflects a decrease of 0.14 or 1.92%. The stock has underperformed its sector by 0.83% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a notable drop in investor participation, with delivery volume falling by 23.79% compared to the 5-day average. The stock's performance over the past week shows a significant decline of 6.40%, while it has seen a modest increase of 4.37% over the past month. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.
In the broader market context, the benchmark Sensex has shown a slight decline of 0.20% over the past week, indicating that the overall market sentiment is relatively stable. However, Boston Bio's performance is notably worse than the benchmark, particularly in the short term. While the Sensex has gained 1.53% over the past month, Boston Bio's 4.37% increase in the same period is overshadowed by its recent downward trend. This suggests that while the stock had a positive month, its current decline is significant compared to both its historical performance and the benchmark's stability.